Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

132 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phase II study assessing lapatinib added to letrozole in patients with progressive disease under aromatase inhibitor in metastatic breast cancer-Study BES 06.
Villanueva C, Romieu G, Salvat J, Chaigneau L, Merrouche Y, N'guyen T, Vuillemin AT, Demarchi M, Dobi E, Pivot X. Villanueva C, et al. Among authors: demarchi m. Target Oncol. 2013 Jun;8(2):137-43. doi: 10.1007/s11523-013-0279-4. Epub 2013 Apr 23. Target Oncol. 2013. PMID: 23609057 Clinical Trial.
Anticancer therapy in patients with porphyrias: evidence today.
Thiery-Vuillemin A, Chaigneau L, Meaux-Ruault N, Villanueva C, N'guyen T, Maurina T, Stein U, Lorgis V, Demarchi M, Pivot X. Thiery-Vuillemin A, et al. Among authors: demarchi m. Expert Opin Drug Saf. 2008 Mar;7(2):159-65. doi: 10.1517/14740338.7.2.159. Expert Opin Drug Saf. 2008. PMID: 18324878
Ixabepilone, a novel epothilone analog in the treatment of breast cancer.
Pivot X, Villanueva C, Chaigneau L, Nguyen T, Demarchi M, Maurina T, Stein U, Borg C. Pivot X, et al. Among authors: demarchi m. Expert Opin Investig Drugs. 2008 Apr;17(4):593-9. doi: 10.1517/13543784.17.4.593. Expert Opin Investig Drugs. 2008. PMID: 18363523 Review.
Ixabepilone: a new active chemotherapy in the treatment of breast cancer.
Villanueva C, Vuillemin AT, Demarchi M, Bazan F, Chaigneau L, Pivot X. Villanueva C, et al. Among authors: demarchi m. Womens Health (Lond). 2009 Mar;5(2):115-21. doi: 10.2217/17455057.5.2.115. Womens Health (Lond). 2009. PMID: 19245349 Free article. Review.
Intraoperative chemotherapy with cisplatin and epinephrine after cytoreductive surgery in patients with recurrent ovarian cancer: a phase I study.
Guardiola E, Chauffert B, Delroeux D, Royer B, Heyd B, Combe M, Benoit L, Causeret S, Demarchi M, Magnin G, Mayer F, Tixier H, Pivot X. Guardiola E, et al. Among authors: demarchi m. Anticancer Drugs. 2010 Mar;21(3):320-5. doi: 10.1097/CAD.0b013e328334d953. Anticancer Drugs. 2010. PMID: 20032778 Clinical Trial.
Safety profile of new anticancer drugs.
Mansi L, Thiery-Vuillemin A, Nguyen T, Bazan F, Calcagno F, Rocquain J, Demarchi M, Villanueva C, Maurina T, Pivot X. Mansi L, et al. Among authors: demarchi m. Expert Opin Drug Saf. 2010 Mar;9(2):301-17. doi: 10.1517/14740330903530663. Expert Opin Drug Saf. 2010. PMID: 20175699 Review.
132 results